chr8-24956246-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM5PP3_Moderate
The NM_006158.5(NEFL):c.270G>C(p.Glu90Asp) variant causes a missense change. The variant allele was found at a frequency of 0.00000434 in 1,611,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E90G) has been classified as Pathogenic.
Frequency
Consequence
NM_006158.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEFL | ENST00000610854.2 | c.270G>C | p.Glu90Asp | missense_variant | Exon 1 of 4 | 1 | NM_006158.5 | ENSP00000482169.2 | ||
ENSG00000272157 | ENST00000607735.2 | n.306C>G | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 | |||||
NEFL | ENST00000615973.1 | n.476G>C | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000409 AC: 1AN: 244732Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 132850
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1459806Hom.: 0 Cov.: 37 AF XY: 0.00000689 AC XY: 5AN XY: 725888
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74338
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.E90D variant (also known as c.270G>C), located in coding exon 1 of the NEFL gene, results from a G to C substitution at nucleotide position 270. The glutamic acid at codon 90 is replaced by aspartic acid, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Charcot-Marie-Tooth disease type 2E Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 90 of the NEFL protein (p.Glu90Asp). This variant is present in population databases (rs767370918, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with NEFL-related conditions. ClinVar contains an entry for this variant (Variation ID: 533516). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NEFL protein function with a positive predictive value of 80%. This variant disrupts the p.Glu90 amino acid residue in NEFL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12566280, 19158810). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at